Cargando…

TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis

Although anti-tumor necrosis factor (TNF) agents are highly effective in the treatment of psoriasis, 2–5% of treated patients develop psoriasis-like skin lesions called paradoxical psoriasis. The pathogenesis of this side effect and its distinction from classical psoriasis remain unknown. Here we sh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conrad, Curdin, Di Domizio, Jeremy, Mylonas, Alessio, Belkhodja, Cyrine, Demaria, Olivier, Navarini, Alexander A., Lapointe, Anne-Karine, French, Lars E., Vernez, Maxime, Gilliet, Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750213/ https://www.ncbi.nlm.nih.gov/pubmed/29295985 http://dx.doi.org/10.1038/s41467-017-02466-4

Ejemplares similares

Psoriasis: Classical vs. Paradoxical. The Yin-Yang of TNF and Type I Interferon
por: Mylonas, Alessio, et al.
Publicado: (2018)

Purpura of the Face and Neck: An Atypical Clinical Presentation Revealing a Hepatosplenic T Cell Lymphoma
por: Kuonen, François, et al.
Publicado: (2014)

Type I IFNs link skin-associated dysbiotic commensal bacteria to pathogenic inflammation and angiogenesis in rosacea
por: Mylonas, Alessio, et al.
Publicado: (2023)

Paradoxical psoriasis induced by TNF‐α blockade shows immunological features typical of the early phase of psoriasis development
por: Fania, Luca, et al.
Publicado: (2019)

Plasmacytoid dendritic cells and regulatory T cells in the tumor microenvironment: A dangerous liaison
por: Conrad, Curdin, et al.
Publicado: (2013)

Plasmacytoid predendritic cells initiate psoriasis through interferon-α production
por: Nestle, Frank O., et al.
Publicado: (2005)

Anti-TNF-Alpha-Induced Psoriasis – An Unusual Paradox
por: Sharma, Neel, et al.
Publicado: (2009)

Differentiation of IL-26(+) T(H)17 intermediates into IL-17A producers via epithelial crosstalk in psoriasis
por: Fries, Anissa, et al.
Publicado: (2023)

Paradoxical psoriasis after the use of anti-TNF in a patient with rheumatoid arthritis
por: de Vasconcellos, Jaqueline Barbeito, et al.
Publicado: (2016)

TNFAIP3 Gene Polymorphisms Are Associated with Response to TNF Blockade in Psoriasis
por: Tejasvi, Trilokraj, et al.
Publicado: (2011)

Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)
por: Wasel, Norman, et al.
Publicado: (2020)

Paradoxical Psoriasis Induced by Anti-TNFα Treatment: Evaluation of Disease-Specific Clinical and Genetic Markers
por: Bucalo, Agostino, et al.
Publicado: (2020)

Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons
por: Gregorio, Josh, et al.
Publicado: (2010)

Nail Involvement as a Predictor of Differential Treatment Effects of Secukinumab Versus Ustekinumab in Patients with Moderate to Severe Psoriasis
por: Conrad, Curdin, et al.
Publicado: (2021)

The TNF Paradox in Cancer Progression and Immunotherapy
por: Montfort, Anne, et al.
Publicado: (2019)

Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved?
por: Jiraskova Zakostelska, Zuzana, et al.
Publicado: (2023)

Skin Barrier Dysregulation in Psoriasis
por: Orsmond, Andreas, et al.
Publicado: (2021)

The biological basis of disease recurrence in psoriasis: a historical perspective and current models
por: Puig, Lluís, et al.
Publicado: (2022)

Paradoxical Flare of Psoriasis after Ustekinumab Therapy
por: Lee, Ho Yeol, et al.
Publicado: (2017)

Corrigendum: The TNF Paradox in Cancer Progression and Immunotherapy
por: Montfort, Anne, et al.
Publicado: (2019)

Paradoxical psoriasis: The flip side of idiopathic psoriasis or an autocephalous reversible drug reaction?
por: Lu, Jiawei, et al.
Publicado: (2023)

Paradoxical Tumor Necrosis Factor-Alpha (TNF-α) Inhibitor-Induced Psoriasis: A Systematic Review of Pathogenesis, Clinical Presentation, and Treatment
por: Chokshi, Aditi, et al.
Publicado: (2023)

Spontaneous Development of Psoriasis in a New Animal Model Shows an Essential Role for Resident T Cells and Tumor Necrosis Factor-α
por: Boyman, Onur, et al.
Publicado: (2004)

A Case of Paradoxical Reactions to Biologic Therapy for Psoriasis
por: Zhou, Qianqian, et al.
Publicado: (2023)

Classical and Paradoxical Effects of TNF-α on Bone Homeostasis
por: Osta, Bilal, et al.
Publicado: (2014)

The cGAS–STING pathway drives type I IFN immunopathology in COVID-19
por: Domizio, Jeremy Di, et al.
Publicado: (2022)

225 Enhanced TLR7 immunity drives innate protection against SARS-CoV-2 with chilblains as collateral damage.
por: Yatim, A., et al.
Publicado: (2023)

Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF–TNF-RII binding in rheumatoid arthritis
por: Nguyen, Dao Xuan, et al.
Publicado: (2016)

Atopic Dermatitis as a Paradoxical Effect of Secukinumab for the Treatment of Psoriasis
por: Mendes Roncada, Eduardo V., et al.
Publicado: (2021)

Elevation of IgE in patients with psoriasis: Is it a paradoxical phenomenon?
por: Shi, Leyao, et al.
Publicado: (2022)

Paradoxical SAPHO Syndrome after Etanercept in a Patient with Psoriasis
por: Gimeno-Castillo, Javier., et al.
Publicado: (2022)

Incidence of and Risk Factors for Paradoxical Psoriasis or Psoriasiform Lesions in Inflammatory Bowel Disease Patients Receiving Anti-TNF Therapy: Systematic Review With Meta-Analysis
por: Xie, Wenhui, et al.
Publicado: (2022)

A plain language summary of what freedom from disease means to people with psoriasis according to doctors, nurses, and people with psoriasis
por: van Ee, Ilse, et al.
Publicado: (2023)

Clinical Course and Characteristics of Generalized Pustular Psoriasis
por: Choon, Siew Eng, et al.
Publicado: (2022)

La piel de los dedos
por: Belkhodja, Katia

Weight-Based Adaptation of TNF-Antagonist Induction versus Maintenance Dose
por: Navarini, Alexander A., et al.
Publicado: (2011)

The Changing Face of Spondyloarthropathies Under TNF α Blockade
por: Elkayam, Ori, et al.
Publicado: (2008)

Hip arthritis in the TNF-Blockade era: an unresolved issue?
por: Scott, C, et al.
Publicado: (2008)

Vaccination under TNF blockade - less effective, but worthwhile
por: Aringer, Martin
Publicado: (2012)

Recalcitrant paradoxical pustular psoriasis induced by infliximab: Two case reports
por: Xia, Ping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t3a41c9cqrn21s0h6h0p58jop9